Compare PFX & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFX | LFVN |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9M | 78.0M |
| IPO Year | N/A | 1996 |
| Metric | PFX | LFVN |
|---|---|---|
| Price | $46.38 | $6.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 34.6K | ★ 81.8K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.57% | 3.56% |
| EPS Growth | N/A | ★ 226.09 |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $203,204,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.53 |
| Revenue Growth | N/A | ★ 1.86 |
| 52 Week Low | $38.30 | $3.90 |
| 52 Week High | $53.00 | $15.00 |
| Indicator | PFX | LFVN |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 55.53 |
| Support Level | $40.93 | $6.05 |
| Resistance Level | $51.45 | $7.00 |
| Average True Range (ATR) | 2.78 | 0.26 |
| MACD | 0.27 | 0.06 |
| Stochastic Oscillator | 64.85 | 69.23 |
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.